About gini
gini is a company based in Toronto (Canada) founded in 2017 by Reetmohinder Singh, Miguel Vesco, and Gurjot Narwal was acquired by Finvasia in October 2021. gini has raised $20 thousand across 2 funding rounds from investors including Finvasia, Techstars and Rangle. The company has 33 employees as of April 05, 2024. gini operates in a competitive market with competitors including InformedDNA, MyOme, Dante Labs, Answer Genomics and ARQUIMEA INGENIERIA, among others.
- Headquarter Toronto, Canada
- Employees 33 as on 05 Apr, 2024
- Founders Reetmohinder Singh, Miguel Vesco, Gurjot Narwal
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gini Health India Private Limited
- Date of Incorporation 09 Nov, 2021
- Jurisdiction Mohali, Punjab, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of gini
Unlock access to complete
Unlock access to complete
Funding Insights of gini
gini has successfully raised a total of $20K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $20 thousand completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in gini
gini has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Finvasia, Techstars and Rangle.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated globally without sector restrictions through structured programs.
|
Locked | Locked | Locked | |
|
Rangle is recognized as an agentic product and platform consultancy.
|
Locked | Locked | Locked | |
|
Online trading in equities, derivatives, currencies, and commodities is enabled.
|
Locked | Locked | Locked |
Investor details for gini
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by gini
Investment portfolio details for gini
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - gini
Detailed financials for gini
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gini Comparisons
Peer comparison for gini
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of gini
gini operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InformedDNA, MyOme, Dante Labs, Answer Genomics and ARQUIMEA INGENIERIA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Network of genetics experts provided to assist patients and providers.
|
|
| Locked | Locked | Locked |
Provider of a platform for gene analysis to determine genetic diseases and drug response
|
|
| Locked | Locked | Locked |
Whole-genome sequencing analysis is offered for health and wellness insights.
|
|
| Locked | Locked | Locked |
Online platform offering DNA-based recommendations for health and wellness
|
|
| Locked | Locked | Locked |
Provider of engineering, manufacturing, and research and development services to industries
|
|
| Locked | Locked | Locked |
Personal genome data is analyzed for health and wellness reports.
|
Detailed competitors of gini
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gini
Complete news archive for gini
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about gini
gini was founded in 2017 and raised its 1st funding round 1 year after it was founded.
gini is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
gini is a funded company, having raised a total of $20K across 2 funding rounds to date.
As of Apr 05, 2024, the latest employee count at gini is 33.
Gini was established in 2017 in Toronto, Canada, within the health technology sector. DNA test kits are distributed for genetic analysis, with results used to generate personalized wellness plans. These plans address nutrition, exercise, sleep, and daily habits through an app-based platform. Operations focus on integrating genetic data into routine health management.
gini's top competitors include Dante Labs, InformedDNA and MyOme.